If you: Have contraindications or complex medical needs requiring in-person care Strongly prefer FDA-approved medications and can access them affordably Want comprehensive support beyond medication (nutrition counseling, behavioral therapy, etc.) Are uncomfortable with the regulatory uncertainty around compounded GLP-1s Cannot commit to long-term treatment costs and requirements Then other pathways - in-person obesity medicine, bariatric surgery evaluation, or continued lifestyle-based approaches with professional support - may serve you better
"Despite obesity being sas a serious chronic illness with long-term consequences, it's often misclassified as a lifestyle choice, resulting in many employers and the federal government excluding medications like Zepbound from insurance coverage," said Jonsson
Monti D, Sotgia F, Whitaker-Menezes D, Tuluc M, Birbe R, Berger A, Lazar M, Cotzia P, Draganova-Tacheva R, Lin Z, Domingo-Vidal M, Newberg A, Lisanti MP, Martinez-Outschoorn U
J Clin Oncol (2013) 31(26):318290
All results are mean SEM and analyzed by 1- or 2-way ANOVA
Using human and mouse models, the researchers have verified that gut flora changes in pSS
